Bonyf NV (XPAR:MLBON) Beta: 0.1388 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLBON Bonyf NV XPAR:MLBON
12 GF Score
Price €2.48
GF Value €8.61
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Bonyf NV Beta?

Bonyf NV XPAR:MLBON 12 Beta is 0.1388 as of Aug. 02, 2026. GuruFocus rates XPAR:MLBON with a GF Score™ of 12/100 and a GF Value™ of €8.61 (Possible Value Trap). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-02), Bonyf NV's Beta is 0.1388.

Bonyf NV  (XPAR:MLBON) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Bonyf NV Beta Related Terms

Bonyf NV Beta Historical Data

* Premium members only.

The historical data trend for Bonyf NV's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonyf NV Beta Chart

Bonyf NV Annual Data
Trend Dec19 Dec20 Dec22 Dec23 Dec24
Beta
0.00 0.00 0.00 0.00 0.00

Bonyf NV Semi-Annual Data
Dec19 Dec20 Dec22 Dec23 Dec24
Beta 0.00 0.00 0.00 0.00 0.00

XPAR:MLBON vs ISRG, BDX, MDLN: Beta Comparison

For the Medical Instruments & Supplies subindustry, Bonyf NV's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bonyf NV Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonyf NV's Beta distribution charts can be found below:

* The bar in red indicates where Bonyf NV's Beta falls into.


XPAR:MLBON
12GF Score
Bonyf NV XPAR:MLBON
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonyf NV Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1388 mean?
Bonyf NV (XPAR:MLBON) has a Beta of 0.1388 as of Aug. 02, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Bonyf NV and its competitors.
Is Bonyf NV's Beta too high?
Bonyf NV's current Beta is 0.1388. Overall, Bonyf NV has a GF Score™ of 12/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonyf NV's Beta compare to ISRG and BDX?
Bonyf NV's Beta of 0.1388 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Bonyf NV and its competitors. Bonyf NV's current Beta is 0.1388. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonyf NV stock overvalued right now?
Based on GuruFocus' analysis, Bonyf NV (XPAR:MLBON) is currently considered Possible Value Trap. The stock's GF Value™ is €8.61, compared to a current price of €2.48 — trading 71.2% below its estimated fair value. The current Beta is 0.1388. Bonyf NV's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Bonyf NV (XPAR:MLBON), the current Beta is 0.1388 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonyf NV (XPAR:MLBON) Overvalued in 2026?

Based on GuruFocus' analysis, Bonyf NV stock appears to be undervalued. The current stock price of €2.48 is trading 71.2% below its estimated GF Value™ of €8.61. GuruFocus considers Bonyf NV to be Possible Value Trap.

Key valuation signals for XPAR:MLBON:

  • Beta: 0.1388
  • GF Value™: €8.61 vs. price of €2.48 (71.2% below fair value)
  • GF Score™: 12/100 with 2 warning signs

No single metric tells the full story. See the XPAR:MLBON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bonyf NV Business Description

Address Kalvekeetdijk 179, box 105, Knokke-Heist, BEL, 8300
Bonyf NV specializes in developing, producing and selling cutting-edge oral & dental care products. It is a forward-thinking company committed to revolutionizing oral care through innovation and research.
12GF Score

Get the complete analysis for XPAR:MLBON

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.48
Price
€8.61
GF Value